The ethical issues associated with germline gene modification and embryo research are some of the most contentious in current international science policy debates. In this paper, we argue that new genetic techniques, such as CRISPR, demonstrate that there is an urgent need for China to develop its own regulatory and ethical framework governing new developments in genetic and embryo research. While China has in place a regulatory framework, it needs to be strengthened to include better compliance oversight and explicit criteria for how different types of research should be reviewed by regulatory authorities. We also document a variety of opinions about the new technologies among the public, scholars, and policy makers. China needs to develop its own regulations in coordination with other countries; but it is unlikely that an international consensus will be achieved in this area, given the existing differences in regulations between countries. We should aim at harmonization, not necessarily complete consensus, and the perspective from China is vital when international norms are developed and harmonized. Chinese policy makers and researchers need to be aware of the international discussions, at the same time as the international community is aware of, and accommodates, Chinese positions on important policy options.

Di Zhang

Reidar K Lie

Monash bioethics review

MONASH BIOETHICS REVIEW 全面涵盖了生物伦理学中的传统主题和新出现的问题。该杂志特别关注具有政策相关性的经验丰富的哲学生命伦理分析。 MONASH BIOETHICS REVIEW 还定期发表实证研究，提供明确的伦理分析和/或具有重大伦理或政策影响。 MONASH BIOETHICS REVIEW 自 1981 年以来由莫纳什大学人类生物伦理学中心（最初为生物伦理学新闻）出版，是澳大利亚历史最悠久的同行评审生物伦理学期刊，也是世界上最古老的生物伦理学期刊之一。一个具有政策相关性的经验丰富的哲学生命伦理分析的国际论坛。包括提供明确的伦理分析和/或具有重大伦理或政策影响的实证研究。最古老的生物伦理学期刊之一，由世界领先的生物伦理学中心出版。发表长达 13,000 字的论文。独特的新功能：所有文章都开放评论

The Monash Bioethics Review comprehensively covers traditional themes and emerging issues in bioethics. The journal particularly focuses on policy-relevant, experienced philosophical analyses of life ethics and regularly publishes empirical research that provides clear ethical analyses and/or has significant ethical or policy implications. Since its inception in 1981, the Monash Bioethics Review has been published by the Monash University Centre for Human Bioethics, making it the oldest peer-reviewed bioethics journal in Australia and one of the oldest bioethics journals in the world. It serves as an international forum for policy-relevant philosophical analyses of life ethics, publishes papers of up to 13,000 words, and features a unique aspect where all articles are open for comment.

《Monash Bioethics Review》全面涵盖生物伦理学中的传统主题和新兴问题。该期刊特别关注与政策相关的经验丰富的哲学生命伦理分析，并定期发表实证研究，提供明确的伦理分析和/或具有重大伦理或政策影响的研究成果。自1981年以来，《Monash Bioethics Review》由莫纳什大学人类生物伦理学中心出版，是澳大利亚历史最悠久的同行评审生物伦理学期刊，也是世界上最古老的生物伦理学期刊之一。它是一个国际论坛，专注于具有政策相关性的哲学生命伦理分析，发表长达13,000字的论文，并且所有文章都开放评论。

Monash Bioethics Review

Monash Bioeth Rev

Ethical issues in human germline gene editing: a perspective from China.

It is argued that new genetic techniques, such as CRISPR, demonstrate that there is an urgent need for China to develop its own regulatory and ethical framework governing new developments in genetic and embryo research.

Ethical issues in human germline gene editing: a perspective from China.

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info

Category	Quartile
ETHICS	2